Results 31 to 40 of about 2,770 (170)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model

open access: yesEJNMMI Physics, 2022
Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to those produced from conventional PET-based dosimetry.
E. Courtney Henry   +11 more
doaj   +1 more source

Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma

open access: yesFrontiers in Oncology, 2021
Arising from the biliary tract, cholangiocarcinoma is a rare and aggressive epithelial cancer. According to the primary site, it can be further classified into intrahepatic, perihilar and distal types.
Antonia Stamatiou   +10 more
doaj   +1 more source

A Clinical Trial of The Evaluation of Environmental Exposure in Yttrium 90 Radioembolization

open access: yesSakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2018
Aim: The aim of this study is to measure the dose rate of twodifferent forms of Y-90 microsphere used for radioembolization and to evaluatethe results according to radiation safety regularities.
Handan Tanyildizi   +2 more
doaj   +1 more source

Radiation segmentectomy for gastric leiomyosarcoma hepatic metastasis [PDF]

open access: yesKorean Journal of Clinical Oncology, 2018
Metastases to the liver can be found in various malignancies, most commonly originating from the colon, rectum, pancreas, stomach, esophagus, breast, lung, and melanoma.
Simon Roh
doaj   +1 more source

Planning Arteriography for Yttrium-90 Microsphere Radioembolization [PDF]

open access: yesSeminars in Interventional Radiology, 2015
Yttrium-90 radioembolization (Y RE) is a contemporary transcatheter locoregional therapy for primary and secondary hepatic malignancies that is commonly utilized in modern Interventional Radiology (IR) practice.1 Unlike other targeted endovascular therapies, such as transarterial chemoembolization (TACE) and transarterial embolization (TAE), the ...
openaire   +2 more sources

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy

open access: yesCase Reports in Radiology, 2012
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy   +5 more
doaj   +1 more source

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla

open access: yesCase Reports in Hepatology, 2014
We report a case of safe and successful yttrium-90 resin microsphere radioembolization in a patient with a long history of multiple recurrent colon cancer hepatic metastases progressing after hepatic resections, hepatic arterial chemotherapy, and ...
Vlasios S. Sotirchos   +7 more
doaj   +1 more source

Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study

open access: yesEJNMMI Physics, 2018
Background Yttrium-90 (90Y) radioembolization involves the intra-arterial delivery of radioactive microspheres to treat hepatic malignancies. Though this therapy involves careful pre-treatment planning and imaging, little is known about the precise ...
Nichole M. Maughan   +14 more
doaj   +1 more source

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres

open access: yesEJNMMI Physics, 2021
Background Multiple post-treatment dosimetry methods are currently under investigation for Yttrium-90 ( $$^{90}\hbox {Y}$$ 90 Y ) radioembolization.
S. Peter Kim   +3 more
doaj   +1 more source

Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

open access: yesJournal of Interventional Medicine, 2023
Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy.
Yasaman Anbari   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy